Dexcom (DXCM) Current Assets (2010 - 2026)

Dexcom (DXCM) has 17 years of Current Assets data on file, last reported at $4.3 billion in Q1 2026.

• Current Assets for Q1 2026 came in at $4.3 billion, down 4.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 billion (down 4.88% YoY), and the FY2025 annual result was $4.0 billion, down 6.23% from the prior year.
• Current Assets advanced to $4.3 billion in Q1 2026 per DXCM's latest filing, from $4.0 billion in the prior quarter.
• Over five years, Current Assets peaked at $5.2 billion in Q3 2025 and troughed at $3.4 billion in Q3 2022.
• A 5-year average of $4.3 billion and a median of $4.3 billion in 2026 frame the typical range for Current Assets.
• The sharpest annual moves came in 2023 and 2024: Current Assets soared 38.25% in 2023, then retreated 9.27% in 2024.
• A 5-year view of Current Assets shows it stood at $3.7 billion in 2022, then gained by 20.64% to $4.4 billion in 2023, then decreased by 2.81% to $4.3 billion in 2024, then declined by 6.23% to $4.0 billion in 2025, then gained by 7.4% to $4.3 billion in 2026.
• Business Quant data shows DXCM's Current Assets at $4.3 billion in Q1 2026, $4.0 billion in Q4 2025, and $5.2 billion in Q3 2025.